Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 216 entries
Sorted by: Best Match Show Resources per page
Functional mutations in 5'UTR of the BMPR2 gene identified in Chinese families with pulmonary arterial hypertension.

Pulmonary circulation

Wang J, Zhang C, Liu C, Wang W, Zhang N, Hadadi C, Huang J, Zhong N, Lu W.
PMID: 27162618
Pulm Circ. 2016 Mar;6(1):103-8. doi: 10.1086/685078.

Pulmonary arterial hypertension (PAH) is a progressive pulmonary vasculopathy with significant morbidity and mortality. Bone morphogenetic protein receptor type 2 (BMPR2) has been well recognized as the principal gene responsible for heritable and sporadic PAH. Four unrelated Chinese patients...

Cite
Wang J, Zhang C, Liu C, et al. Functional mutations in 5'UTR of the BMPR2 gene identified in Chinese families with pulmonary arterial hypertension. Pulm Circ. 2016;6(1):103-8doi: 10.1086/685078.
Wang, J., Zhang, C., Liu, C., Wang, W., Zhang, N., Hadadi, C., Huang, J., Zhong, N., & Lu, W. (2016). Functional mutations in 5'UTR of the BMPR2 gene identified in Chinese families with pulmonary arterial hypertension. Pulmonary circulation, 6(1), 103-8. https://doi.org/10.1086/685078
Wang, Jian, et al. "Functional mutations in 5'UTR of the BMPR2 gene identified in Chinese families with pulmonary arterial hypertension." Pulmonary circulation vol. 6,1 (2016): 103-8. doi: https://doi.org/10.1086/685078
Wang J, Zhang C, Liu C, Wang W, Zhang N, Hadadi C, Huang J, Zhong N, Lu W. Functional mutations in 5'UTR of the BMPR2 gene identified in Chinese families with pulmonary arterial hypertension. Pulm Circ. 2016 Mar;6(1):103-8. doi: 10.1086/685078. PMID: 27162618; PMCID: PMC4860546.
Copy Download .nbib Format: NLM
WWOX suppresses KLF5 expression and breast cancer cell growth.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Ge F, Chen W, Yang R, Zhou Z, Chang N, Chen C, Zou T, Liu R, Tan J, Ren G.
PMID: 25400415
Chin J Cancer Res. 2014 Oct;26(5):511-6. doi: 10.3978/j.issn.1000-9604.2014.09.03.

The WW domain-containing oxidoreductase (WWOX) is a tumor suppressor in a variety of cancers, including breast cancer. Reduced WWOX expression is associated with the basal-like subtype and a relatively poor disease-free survival rate among breast cancer patients. Though several...

Cite
Ge F, Chen W, Yang R, et al. WWOX suppresses KLF5 expression and breast cancer cell growth. Chin J Cancer Res. 2014;26(5):511-6doi: 10.3978/j.issn.1000-9604.2014.09.03.
Ge, F., Chen, W., Yang, R., Zhou, Z., Chang, N., Chen, C., Zou, T., Liu, R., Tan, J., & Ren, G. (2014). WWOX suppresses KLF5 expression and breast cancer cell growth. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 26(5), 511-6. https://doi.org/10.3978/j.issn.1000-9604.2014.09.03
Ge, Fei, et al. "WWOX suppresses KLF5 expression and breast cancer cell growth." Chinese journal of cancer research = Chung-kuo yen cheng yen chiu vol. 26,5 (2014): 511-6. doi: https://doi.org/10.3978/j.issn.1000-9604.2014.09.03
Ge F, Chen W, Yang R, Zhou Z, Chang N, Chen C, Zou T, Liu R, Tan J, Ren G. WWOX suppresses KLF5 expression and breast cancer cell growth. Chin J Cancer Res. 2014 Oct;26(5):511-6. doi: 10.3978/j.issn.1000-9604.2014.09.03. PMID: 25400415; PMCID: PMC4220264.
Copy Download .nbib Format: NLM
Lower airway inflammation and hyperresponsiveness in non-asthmatic patients with non-allergic rhinitis.

Journal of thoracic disease

Wang Q, Ji J, Xie Y, Guan W, Zhang Y, Wang Z, Wu K, Zhong N.
PMID: 26623098
J Thorac Dis. 2015 Oct;7(10):1756-64. doi: 10.3978/j.issn.2072-1439.2015.10.26.

BACKGROUND: Potential associations between non-allergic rhinitis (NAR) and asthma have been verified epidemiologically, but these associations remain not very clear. It is necessary to further explore the possible implication of lower airway abnormities in NAR patients but without asthma....

Cite
Wang Q, Ji J, Xie Y, et al. Lower airway inflammation and hyperresponsiveness in non-asthmatic patients with non-allergic rhinitis. J Thorac Dis. 2015;7(10):1756-64doi: 10.3978/j.issn.2072-1439.2015.10.26.
Wang, Q., Ji, J., Xie, Y., Guan, W., Zhang, Y., Wang, Z., Wu, K., & Zhong, N. (2015). Lower airway inflammation and hyperresponsiveness in non-asthmatic patients with non-allergic rhinitis. Journal of thoracic disease, 7(10), 1756-64. https://doi.org/10.3978/j.issn.2072-1439.2015.10.26
Wang, Qiuping, et al. "Lower airway inflammation and hyperresponsiveness in non-asthmatic patients with non-allergic rhinitis." Journal of thoracic disease vol. 7,10 (2015): 1756-64. doi: https://doi.org/10.3978/j.issn.2072-1439.2015.10.26
Wang Q, Ji J, Xie Y, Guan W, Zhang Y, Wang Z, Wu K, Zhong N. Lower airway inflammation and hyperresponsiveness in non-asthmatic patients with non-allergic rhinitis. J Thorac Dis. 2015 Oct;7(10):1756-64. doi: 10.3978/j.issn.2072-1439.2015.10.26. PMID: 26623098; PMCID: PMC4635304.
Copy Download .nbib Format: NLM
Basiliximab induction therapy in kidney transplantation: benefits for long term allograft function after 10 years?.

Biologics : targets & therapy

Koch M, Becker T, Lueck R, Neipp M, Klempnauer J, Nashan B.
PMID: 19707395
Biologics. 2009;3:51-6. doi: 10.2147/btt.2009.2781. Epub 2009 Jul 13.

The interleukin-2 receptor antagonist basiliximab has proven in large clinical trials to be safe and effective to reduce acute rejections in the first year after renal transplantation. Since acute rejections are a risk factor for chronic graft loss, their...

Cite
Koch M, Becker T, Lueck R, et al. Basiliximab induction therapy in kidney transplantation: benefits for long term allograft function after 10 years?. Biologics. 2009;3:51-6doi: 10.2147/btt.2009.2781.
Koch, M., Becker, T., Lueck, R., Neipp, M., Klempnauer, J., & Nashan, B. (2009). Basiliximab induction therapy in kidney transplantation: benefits for long term allograft function after 10 years?. Biologics : targets & therapy, 351-6. https://doi.org/10.2147/btt.2009.2781
Koch, Martina, et al. "Basiliximab induction therapy in kidney transplantation: benefits for long term allograft function after 10 years?." Biologics : targets & therapy vol. 3 (2009): 51-6. doi: https://doi.org/10.2147/btt.2009.2781
Koch M, Becker T, Lueck R, Neipp M, Klempnauer J, Nashan B. Basiliximab induction therapy in kidney transplantation: benefits for long term allograft function after 10 years?. Biologics. 2009;3:51-6. doi: 10.2147/btt.2009.2781. Epub 2009 Jul 13. PMID: 19707395; PMCID: PMC2726070.
Copy Download .nbib Format: NLM
Chest tightness variant asthma: deja vu all over again.

Journal of thoracic disease

Zhong N.
PMID: 24822094
J Thorac Dis. 2014 May;6(5):407-8. doi: 10.3978/j.issn.2072-1439.2014.03.02.

No abstract available.

Cite
Zhong N. Chest tightness variant asthma: deja vu all over again. J Thorac Dis. 2014;6(5):407-8doi: 10.3978/j.issn.2072-1439.2014.03.02.
Zhong, N. (2014). Chest tightness variant asthma: deja vu all over again. Journal of thoracic disease, 6(5), 407-8. https://doi.org/10.3978/j.issn.2072-1439.2014.03.02
Zhong, Nanshan. "Chest tightness variant asthma: deja vu all over again." Journal of thoracic disease vol. 6,5 (2014): 407-8. doi: https://doi.org/10.3978/j.issn.2072-1439.2014.03.02
Zhong N. Chest tightness variant asthma: deja vu all over again. J Thorac Dis. 2014 May;6(5):407-8. doi: 10.3978/j.issn.2072-1439.2014.03.02. PMID: 24822094; PMCID: PMC4015016.
Copy Download .nbib Format: NLM
Corticosteroid monotherapy in a case of bronchocentric granulomatosis with a two-year follow-up.

Journal of thoracic disease

Li H, He J, Gu Y, Zhong N.
PMID: 24255794
J Thorac Dis. 2013 Oct;5(5):E207-9. doi: 10.3978/j.issn.2072-1439.2013.10.13.

Bronchocentric granulomatosis (BCG) is a rare disease. Because of the possibility of fungal infection, BCG has usually been treated with corticosteroids and antifungal agent. However, fungi are not detected in all BCG tissues. We report a case of proven...

Cite
Li H, He J, Gu Y, et al. Corticosteroid monotherapy in a case of bronchocentric granulomatosis with a two-year follow-up. J Thorac Dis. 2013;5(5):E207-9doi: 10.3978/j.issn.2072-1439.2013.10.13.
Li, H., He, J., Gu, Y., & Zhong, N. (2013). Corticosteroid monotherapy in a case of bronchocentric granulomatosis with a two-year follow-up. Journal of thoracic disease, 5(5), E207-9. https://doi.org/10.3978/j.issn.2072-1439.2013.10.13
Li, Huiling, et al. "Corticosteroid monotherapy in a case of bronchocentric granulomatosis with a two-year follow-up." Journal of thoracic disease vol. 5,5 (2013): E207-9. doi: https://doi.org/10.3978/j.issn.2072-1439.2013.10.13
Li H, He J, Gu Y, Zhong N. Corticosteroid monotherapy in a case of bronchocentric granulomatosis with a two-year follow-up. J Thorac Dis. 2013 Oct;5(5):E207-9. doi: 10.3978/j.issn.2072-1439.2013.10.13. PMID: 24255794; PMCID: PMC3815734.
Copy Download .nbib Format: NLM
Psychoonkologische Versorgung von Melanompatienten in zertifizierten Hautkrebszentren.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Meiss F, Loquai C, Weis J, Giesler JM, Reuter K, Nashan D.
PMID: 29750470
J Dtsch Dermatol Ges. 2018 May;16(5):577-584. doi: 10.1111/ddg.13521_g.

No abstract available.

Cite
Meiss F, Loquai C, Weis J, et al. Psychoonkologische Versorgung von Melanompatienten in zertifizierten Hautkrebszentren. J Dtsch Dermatol Ges. 2018;16(5):577-584doi: 10.1111/ddg.13521_g.
Meiss, F., Loquai, C., Weis, J., Giesler, J. M., Reuter, K., & Nashan, D. (2018). Psychoonkologische Versorgung von Melanompatienten in zertifizierten Hautkrebszentren. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 16(5), 577-584. https://doi.org/10.1111/ddg.13521_g
Meiss, Frank, et al. "Psychoonkologische Versorgung von Melanompatienten in zertifizierten Hautkrebszentren." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 16,5 (2018): 577-584. doi: https://doi.org/10.1111/ddg.13521_g
Meiss F, Loquai C, Weis J, Giesler JM, Reuter K, Nashan D. Psychoonkologische Versorgung von Melanompatienten in zertifizierten Hautkrebszentren. J Dtsch Dermatol Ges. 2018 May;16(5):577-584. doi: 10.1111/ddg.13521_g. PMID: 29750470.
Copy Download .nbib Format: NLM
[Erratum to: Therapy of herpes zoster and postherpetic neuralgia].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete

Hüning S, von Dücker L, Kohl WK, Nashan D.
PMID: 31482273
Hautarzt. 2019 Sep;70(9):690. doi: 10.1007/s00105-019-04476-3.

No abstract available.

Cite
Hüning S, von Dücker L, Kohl WK, et al. Erratum zu: Therapie des Herpes zoster und der postherpetischen Neuralgie. [Erratum to: Therapy of herpes zoster and postherpetic neuralgia]. Hautarzt. 2019;70(9):690doi: 10.1007/s00105-019-04476-3.
Hüning, S., von Dücker, L., Kohl, W. K., & Nashan, D. (2019). Erratum zu: Therapie des Herpes zoster und der postherpetischen Neuralgie. [Erratum to: Therapy of herpes zoster and postherpetic neuralgia]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 70(9), 690. https://doi.org/10.1007/s00105-019-04476-3
Hüning, S, et al. "Erratum zu: Therapie des Herpes zoster und der postherpetischen Neuralgie." [Erratum to: Therapy of herpes zoster and postherpetic neuralgia]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete vol. 70,9 (2019): 690. doi: https://doi.org/10.1007/s00105-019-04476-3
Hüning S, von Dücker L, Kohl WK, Nashan D. Erratum zu: Therapie des Herpes zoster und der postherpetischen Neuralgie. [Erratum to: Therapy of herpes zoster and postherpetic neuralgia]. Hautarzt. 2019 Sep;70(9):690. doi: 10.1007/s00105-019-04476-3. German. PMID: 31482273.
Copy Download .nbib Format: NLM
Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection.

Oncotarget

von Felden J, Schulze K, Krech T, Ewald F, Nashan B, Pantel K, Lohse AW, Riethdorf S, Wege H.
PMID: 29163804
Oncotarget. 2017 Sep 23;8(52):89978-89987. doi: 10.18632/oncotarget.21208. eCollection 2017 Oct 27.

BACKGROUND: Early hepatocellular carcinoma (HCC) has a limited prognosis due to recurrence rates of more than 50% after liver resection. Recurrence within two years is believed to be caused by untraceable micro metastases at the time of resection. The...

Cite
von Felden J, Schulze K, Krech T, et al. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection. Oncotarget. 2017;8(52):89978-89987doi: 10.18632/oncotarget.21208.
von Felden, J., Schulze, K., Krech, T., Ewald, F., Nashan, B., Pantel, K., Lohse, A. W., Riethdorf, S., & Wege, H. (2017). Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection. Oncotarget, 8(52), 89978-89987. https://doi.org/10.18632/oncotarget.21208
von Felden, Johann, et al. "Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection." Oncotarget vol. 8,52 (2017): 89978-89987. doi: https://doi.org/10.18632/oncotarget.21208
von Felden J, Schulze K, Krech T, Ewald F, Nashan B, Pantel K, Lohse AW, Riethdorf S, Wege H. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection. Oncotarget. 2017 Sep 23;8(52):89978-89987. doi: 10.18632/oncotarget.21208. eCollection 2017 Oct 27. PMID: 29163804; PMCID: PMC5685725.
Copy Download .nbib Format: NLM
Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells.

Cell communication and signaling : CCS

Schmitt MJ, Philippidou D, Reinsbach SE, Margue C, Wienecke-Baldacchino A, Nashan D, Behrmann I, Kreis S.
PMID: 23245396
Cell Commun Signal. 2012 Dec 17;10(1):41. doi: 10.1186/1478-811X-10-41.

BACKGROUND: The type-II-cytokine IFN-γ is a pivotal player in innate immune responses but also assumes functions in controlling tumor cell growth by orchestrating cellular responses against neoplastic cells. The role of IFN-γ in melanoma is not fully understood: it...

Cite
Schmitt MJ, Philippidou D, Reinsbach SE, et al. Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell Commun Signal. 2012;10(1):41doi: 10.1186/1478-811X-10-41.
Schmitt, M. J., Philippidou, D., Reinsbach, S. E., Margue, C., Wienecke-Baldacchino, A., Nashan, D., Behrmann, I., & Kreis, S. (2012). Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell communication and signaling : CCS, 10(1), 41. https://doi.org/10.1186/1478-811X-10-41
Schmitt, Martina J, et al. "Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells." Cell communication and signaling : CCS vol. 10,1 (2012): 41. doi: https://doi.org/10.1186/1478-811X-10-41
Schmitt MJ, Philippidou D, Reinsbach SE, Margue C, Wienecke-Baldacchino A, Nashan D, Behrmann I, Kreis S. Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell Commun Signal. 2012 Dec 17;10(1):41. doi: 10.1186/1478-811X-10-41. PMID: 23245396; PMCID: PMC3541122.
Copy Download .nbib Format: NLM
The incidence and severity of post-hepatectomy bile leaks is affected by surgical indications, preoperative chemotherapy, and surgical procedures.

Hepatobiliary surgery and nutrition

Spetzler VN, Schepers M, Pinnschmidt HO, Fischer L, Nashan B, Li J.
PMID: 31098357
Hepatobiliary Surg Nutr. 2019 Apr;8(2):101-110. doi: 10.21037/hbsn.2019.02.06.

BACKGROUND: Bile leaks are one of the most common complications after liver resection. The International Study Group of Liver Surgery (ISGLS) established a uniform bile leak definition including a severity grading. However, a risk factor assessment according to ISGLS...

Cite
Spetzler VN, Schepers M, Pinnschmidt HO, et al. The incidence and severity of post-hepatectomy bile leaks is affected by surgical indications, preoperative chemotherapy, and surgical procedures. Hepatobiliary Surg Nutr. 2019;8(2):101-110doi: 10.21037/hbsn.2019.02.06.
Spetzler, V. N., Schepers, M., Pinnschmidt, H. O., Fischer, L., Nashan, B., & Li, J. (2019). The incidence and severity of post-hepatectomy bile leaks is affected by surgical indications, preoperative chemotherapy, and surgical procedures. Hepatobiliary surgery and nutrition, 8(2), 101-110. https://doi.org/10.21037/hbsn.2019.02.06
Spetzler, Vinzent N, et al. "The incidence and severity of post-hepatectomy bile leaks is affected by surgical indications, preoperative chemotherapy, and surgical procedures." Hepatobiliary surgery and nutrition vol. 8,2 (2019): 101-110. doi: https://doi.org/10.21037/hbsn.2019.02.06
Spetzler VN, Schepers M, Pinnschmidt HO, Fischer L, Nashan B, Li J. The incidence and severity of post-hepatectomy bile leaks is affected by surgical indications, preoperative chemotherapy, and surgical procedures. Hepatobiliary Surg Nutr. 2019 Apr;8(2):101-110. doi: 10.21037/hbsn.2019.02.06. PMID: 31098357; PMCID: PMC6503260.
Copy Download .nbib Format: NLM
High-dose gatifloxacin-based shorter treatment regimens for MDR/RR-TB.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Nie Q, Tao L, Li Y, Chen N, Chen H, Zhou Y, Wang Y, Chen H, Tang Q, Wang X, Huang C, Yang C.
PMID: 34861398
Int J Infect Dis. 2021 Nov 30; doi: 10.1016/j.ijid.2021.11.037. Epub 2021 Nov 30.

SETTING: The shorter treatment regimen (STR) for multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) has achieved successful outcomes in many countries. However, there are few studies on high-dose gatifloxacin-based STR with adverse drug reactions (ADRs) and management.DESIGN: A prospective observational study...

Cite
Nie Q, Tao L, Li Y, et al. High-dose gatifloxacin-based shorter treatment regimens for MDR/RR-TB. Int J Infect Dis. 2021;doi: 10.1016/j.ijid.2021.11.037.
Nie, Q., Tao, L., Li, Y., Chen, N., Chen, H., Zhou, Y., Wang, Y., Chen, H., Tang, Q., Wang, X., Huang, C., & Yang, C. (2021). High-dose gatifloxacin-based shorter treatment regimens for MDR/RR-TB. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, . https://doi.org/10.1016/j.ijid.2021.11.037
Nie, Qi, et al. "High-dose gatifloxacin-based shorter treatment regimens for MDR/RR-TB." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. (2021). doi: https://doi.org/10.1016/j.ijid.2021.11.037
Nie Q, Tao L, Li Y, Chen N, Chen H, Zhou Y, Wang Y, Chen H, Tang Q, Wang X, Huang C, Yang C. High-dose gatifloxacin-based shorter treatment regimens for MDR/RR-TB. Int J Infect Dis. 2021 Nov 30; doi: 10.1016/j.ijid.2021.11.037. Epub 2021 Nov 30. PMID: 34861398.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 216 entries